eXceed Symposia 2021

By Bruker

Expanding the Horizons of Single Cell Research

In August 2019, the article “A dream of single-cell proteomics” in Nature Methods’ Technology Feature stated that “Nowadays, labs can generate massive sets of single-cell genomic and single-cell transcriptomic data. In proteomics, high-throughput single-cell methods have not yet arrived”. [1]

In June 2021, two years later, this dream comes true. Cutting edge proteomics experiments demand the most sensitive mass spectrometer requiring very high sensitivity with limited sample material. Join our eXceed Symposia on “Expanding the Horizons of Single Cell Research” to hear about the quantum leap in this exciting area.

 

 

​Day 1: Tuesday, June 1, 10:00 am EDT

10:00 – 10:30 Introduction
Rohan Thakur, Ph.D., Managing Director and Executive Vice President, Life Sciences Mass Spectrometry, Bruker Daltonik GmbH, Bremen, Germany

10:30 – 11:10 True single cell and deep visual proteomics on the Bruker timsTOF
Prof. Matthias Mann, Ph.D., Director, Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, Martinsried, Germany

11:10 – 11:50 Imaging Single Cell Tissue Networks
Prof. Ron Heeren, Ph.D., Division Head Imaging Mass Spectrometry, Maastricht University, Maastricht, Netherlands

11:50 – 12:10 Q&A and Closing
Gary H. Kruppa, Ph.D., Vice President, Proteomics, Bruker Daltonics, Billerica, MA

One registration covers all three days

 

 

Day 2: Wednesday June 2, 10:00 am EDT​

10:00 – 10:30 Introduction
Rohan Thakur, Ph.D., Managing Director and Executive Vice President, Life Sciences Mass Spectrometry, Bruker Daltonik GmbH, Bremen, Germany

10:30 – 11:10 Quantitative proteomics with the timsTOF Pro
Prof. John Yates III, Ph.D., Department of Molecular Medicine, Scripps Research, La Jolla, CA, USA

11:10  11:50 Recent Developments in MALDI-2- and t-MALDI-2 Imaging
Prof. Klaus Dreisewerd, Ph.D., Team Leader Section Biomedical Mass Spectrometry, University of Münster, Münster, Germany

11:50 – 12:10 Q&A and Closing
Michael Easterling, Ph.D., Business Unit Manager, Imaging/MRMS, Bruker Daltonics, Billerica, MA, USA

One registration covers all three days

 

 

Day 3: Thursday, June 4, 2021, 10 am EDT Bruker Partner and Guest Speakers

10:00 – 10:05 Introduction
Chris Adams, Ph.D., Business Development Director, Global  Bioinformatics, Life Science Mass Spectrometry, Bruker Daltonics, Billerica, MA, USA

10:05 – 10:20 Plasma proteomics using Proteograph with the timsTOF Pro
Daniele Hornburg, Scientist, Seer Inc., 3800 Bridge Parkway, Suite 102, Redwood City, CA 94065, USA

10:20 – 10:35 Unleashing the power of dia-PASEF with the Evosep One
Nicolai Bache, Ph.D., Head of Applications, Evosep Biosystems, Buchwaldsgade 35, 3., 5000 Odense, Denmark

10:35 – 10:50 Streamlined & automated sample processing for in-depth proteomic analyses
Garwin Pichler, Ph.D., CEO, PreOmics GmbH, ‍Am Klopferspitz 19, 82152 Planegg/Martinsried, Germany

10:50 – 11:05 High-throughput clinical proteomics and applications to COVID-19
Philipp E. Geyer, Ph.D., CSO, OmicEra Diagnostics GmbH, Behringstr. 6, 82152 Planegg, Germany

11:05 – 11:20 4D Proteomics Using Biognosys Software
Fabia Simona, Ph.D., Scientific Business Development Manager, Biognosys AG, Wagistrasse 21, 8952 Schlieren, Switzerland

11:20 – 11:35 More stable, higher depth, and More trace amount: analysis of protein post-translational modifications based on parallel accumulation – serial fragmentation combined with data-independent acquisition (diaPASEF) mode
Li Ziyi, Ph.D., Senior R&D Specialist, Shanghai Applied Protein Technology Co., Ltd., Shanghai, China

11:35 – 11:45 Q&A and Closing
Lucy Woods, Ph.D., Business Unit Manager Phenomics and Metabolomics, Bruker Daltonics, Billerica, MA, USA

When: June 1 – 3, 2021

 

Where: will show after the early registration

 

Early registration link:  Click here

 

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

 
Keynote Speakers

Prof. Matthias Mann, Ph.D.,
Director, Department of Proteomics and Signal Transduction, Max-Planck-Institute of Biochemistry, Martinsried, Germany

 

Prof. Ron Heeren, Ph.D.,
Division Head Imaging Mass Spectrometry, Maastricht University, Maastricht, Netherlands

 

Prof. John Yates III,
Ph.D., The Scripps Research Institute, Molecular Medicine, La Jolla, CA, USA

 

Prof. Klaus Dreisewerd,
Ph.D., Leader Section Biomedical Mass Spectrometry, University of Muenster, Germany